Work

S931 Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR)

Year: 2021

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000777256.07149.aa

Authors: Millie D. Long, Anita Afzali, Monika Fisher, Emily English, Xian Zhang, David Hudesman, Maisa Abdalla, Robert P. McCabe, Benjamin Cohen, William Harlan, John Hanson, Gauree G. Konijeti, Steven Polyak, Timothy E. Ritter, Bruce Salzberg, Hans Herfarth

Institutions: University of North Carolina at Chapel Hill, The Ohio State University Wexner Medical Center, Indiana University Indianapolis, New York University, University of Rochester, MNGI Digestive Health, Cleveland Clinic, Canadian Association of Gastroenterology, Scripps Clinic, University of Iowa, Atlanta Gastroenterology Associates

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3208450294

Cites:

Cited by:

Related to: 10